Y-mAbs Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Y-mAbs Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $346K, a 85% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $801K, a 119% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $561K.
  • Y-mAbs Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Y-mAbs Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $561K +$561K Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.